Explore
Validate
Learn
Western blot
Other assayAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-25258 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- DHRS2 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 400 µL
- Concentration
- 0.5 mg/mL
- Storage
- Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Submitted references DHRS2 mediates cell growth inhibition induced by Trichothecin in nasopharyngeal carcinoma.
DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma.
Luo X, Li N, Zhao X, Liao C, Ye R, Cheng C, Xu Z, Quan J, Liu J, Cao Y
Journal of experimental & clinical cancer research : CR 2019 Jul 10;38(1):300
Journal of experimental & clinical cancer research : CR 2019 Jul 10;38(1):300
DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma.
Zhou Y, Wang L, Ban X, Zeng T, Zhu Y, Li M, Guan XY, Li Y
Oncogene 2018 Feb 22;37(8):1086-1094
Oncogene 2018 Feb 22;37(8):1086-1094
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 1 DHRS2 downregulation was significantly associated with poorer prognosis of ESCC. ( a ) The representative pictures of DHRS2 staining in ESCC tumor tissue and paired non-tumor tissue. The boxed regions were magnified and shown in the right panels. ( b ) Kaplan-Meier analysis showed that DHRS2 downregulation was significantly associated with ESCC patients' poorer survival. ( c ) The relative quantification of DHRS2-V1 and DHRS2-V2 in ESCC cell lines, NE1 (an immortalized human esophageal epithelial cell line) and non-tumor esophageal tissues pool (three cases).
